Catalyst Wire Dossier Catalyst Wire Dossier

RELAFEN DS

nabumetone · Carwin Pharmaceutical Associates, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RELAFEN DS, covering 2019-08-30 to 2024-11-22. Get the full timeline:

Most recent: FDA Approved: RELAFEN DS — Supplemental Application (Carwin Pharmaceutical Associates, LLC)

See pricing